going to come to your house and adjust your diet, exercise schedule etc.
http://www.lef.org/whatshot/2010_09.htmEPA shows promise for metabolic syndrome
An article published online on September 1, 2010 in the journal Diabetes revealed the discovery of researchers in Japan of an antiobesity effect for the omega-3 fatty acid eicosapentaenoic acid (EPA) in a study of mice given diets containing a high amount of fat and sugar (sucrose). Western diets containing high amounts of fat and sugar have been implicated in metabolic syndrome, a cluster of symptoms that increase the risk of diabetes.
In their introduction to the article, the authors remark that visceral fat is a key factor in the development of metabolic syndrome, and that enhanced production of fat by the liver and fatty liver disease also play a role in the condition. In four experiments, male mice were fed a high fat diet or a high fat/high sucrose diet with or without the addition of EPA for 4 to 20 weeks. While obesity developed in those that received the high fat diet as well as those that received the high fat/high sucrose diet, liver lipogenic enzymes increased, the development of fatty liver was more severe and hyperinsulinemia developed more rapidly in the latter group. Eicosapentaenoic acid added to the high fat, high sucrose diet resulted in reduced weight gain and obesity-associated elevations in blood glucose and insulin, while it had no effect on obesity in mice given high fat diets. The authors suggest that suppression of enhanced hepatic fat production contributes to EPA’s antiobesity effect.
“This study is the first demonstration that the antiobesity effect of EPA in high fat/high sucrose-induced obesity is associated with the suppression of hepatic lipogenesis and steatosis,” the authors announce. “Because the metabolic syndrome is often associated with hepatic lipogenesis and steatosis, the data of this study suggest that EPA is suited for the treatment of the metabolic syndrome.”